Immediate Management Prof Nigel Harper Clinical Lead, NAP6

Slides:



Advertisements
Similar presentations
Dr Bronwyn Avard, July 2010  To understand the basic physiology of shock  To understand the pharmacodynamics and pharmacokinetics of vasoactive drugs.
Advertisements

Anaphylaxis SHO presentation Tom Francis ICU Registrar.
SEPSIS KILLS program Paediatric Inpatients
The New Surviving Sepsis Bundles: From Time Zero to Tomorrow
Wes Theurer, DO.  Recognize sepsis early  Understand therapeutic principles  Cultures before antibiotics  Crystalloid fluid resuscitation  Antimicrobials.
Anaesthetic Emergencies Acute Anaphylaxis Dr T E Allan Palmer FRCA FANZCA MD
Magnesium sulphate in the Management of Eclampsia in Malawi Dr. Chisale Mhango FRCOG 1 NPC Training in MNH.
Triage Nurse Initiation of Corticosteroids in Paediatric Asthma is Associated With Improved Emergency Department Efficiency Zemak et al Pediatrics Volume.
Cardiopulmonary Resuscitation Shamiel Salie Paediatric Intensive Care Unit Red Cross Children’s Hospital, University of Cape Town.
Anaphylaxis By : O. Ahmadi, MD. Professor Assistant of Esfahan medical School, Emergency Department of Al-Zahra Hospital.
The Vexing Problem of Vasoplegia
PHARMAKOLOGY VASOPRESSOR DRUGS DJUDJUK RAHMAD BASUKI Lab.Anestesi dan Terapi Intensive RSSA Malang.
Emergency management of complications of thrombolysis C. Roffe The recommendations in this presentation are for guidance only. Guidance based on ASA recommendations.
Anaphylaxis. Severe Anaphylactic Reactions Manifestation Respiratory difficulty Signs of shock/hypotension Involvement of skin/mucosal tissue GI symptoms.
Allergic Reactions and You Dana Daidone D.O.. Onset of Reaction Usually within minutes after injection 80% occur on induction 15% during maintenance 5%
Anaphylaxis: Rapid recognition and treatment Miha Mežnar MD Medical intensive care unit General hospital Celje, Slovenia.
A NAPHYLAXIS M ANAGEMENT. 3 R S FOR T REATING A NAPHYLAXIS.
BANGALORE BAPTIST HOSPITAL Snakebite Study Workshop Vellore, Mar 2013 Dr Tarun/ Dr Indira Menon.
Vasopressors in shock Diane J Lum, PharmD, BCACP Stony Brook University Hospital 9/30/15 1.
References 1.Royal College of Anaesthetists 3 rd National Audit Project (NAP3) Major Complications of Central Neuraxial Block in the United Kingdom, Report.
Mohan Kamalanathan Emergency Department Frankston Hospital
United States Statistics on Sepsis
NAP6 Perioperative Anaphylaxis The Royal College of Anaesthetists’ 6 th National Audit Project Starting on 5 th February 2016.
 Using conventional ionic contrast agents, total adverse reactions can be expected with a frequency of ~5-8%  Adverse reactions from intravascular contrast.
A pilot randomized controlled trial Registry #: NCT
M ANAGEMENT OF ACUTE SEVERE ASTHMA Dr: MUHAMMED AL,OBAIDY CHEST PHYSCIAN MEDICAL CITY.
Anaphylaxis.
SEVERE SEPSIS AND SEPTIC SHOCK
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated May 26, 2017.
Yadegarynia, D. MD..
Resuscitation in special circumstances workshop Anaphylaxis
Unit 3 Lesson 5 General Pharmacology for ALS
Foundations of Interprofessional Collaboration (FIPC): An Introduction to TeamSTEPPS® LEVEL 3 Overview of Clinical Management of Anaphylaxis for Nursing.
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated August 30, 2017.
Management of a Brain dead donor until retrieval of organs
NAP6 Perioperative Anaphylaxis
SEPSIS COLLABORATIVE Clinical Measures Scorecard Classification
Emergency Care Part 3: Surgery in Children with Diabetes
Foundations of Interprofessional Collaboration (FIPC): An Introduction to TeamSTEPPS® LEVEL 3 Overview of Clinical Management of Anaphylaxis for Health.
Foundations of Interprofessional Collaboration (FIPC): An Introduction to TeamSTEPPS® LEVEL 3 Overview of Clinical Management of Anaphylaxis for Respiratory.
Sensitivity Analyses Intraoperative neuromuscular blocking agent administration and hospital readmission Sub-cohort Frequency of readmitted patients (percent.
Advanced Life Support.
Anaphylaxis and angioedema
Rare ……..But it could be YOU!
Cardiovascular Support in ICU
Foundations of Interprofessional Collaboration (FIPC): An Introduction to TeamSTEPPS® LEVEL 3 Overview of Clinical Management of Anaphylaxis for Pharmacy.
Relative Adrenal Insufficiency
Overview and Key Findings Prof Nigel Harper Clinical Lead, NAP6
CLINICAL FEATURES Dr K-L Kong, MD MBBS FRCA, Consultant Anaesthetist Dr Surendra Karanam, BSc MBBS MRCP FRCP FRCPath, Consultant Immunologist.
Obstetrics Nuala Lucas OAA
Calcium Chloride Christopher J. Fullagar, MD, EMT-P, FACEP
NAP6 – deaths, cardiac arrests, profound hypotension and outcomes Tim Cook Director of NAP program Consultant Anaesthesia/Intensive Care, Bath.
Antibiotics Shuaib Nasser Cambridge University Hospitals NHS Foundation Trust NAP6 Steering Committee member.
NAP6 Paediatric cases Mark Thomas Paediatric Anaesthetist Great Ormond Street Hospital, London Council member, Association of Paedaitrc Anaesthetists.
Treatment of acute asthma
“Acute anaphylaxis” and “anaphylactic reactions”
The Research Question In non-asthmatic adults presenting to primary care with acute lower respiratory tract infection and not requiring immediate antibiotics.
STRONG RECOMMENDATIONS (appendix A)
NAP6 – the independent/private sector m Tim Cook Director of NAP program Consultant Anaesthesia/Intensive Care, Bath.
What we already know Most studies have shown that NMBAs are the commonest cause (44-60%)of perioperative anaphylaxis Previous studies have been hampered.
What We Already Know Reported as a cause of anaphylaxis since the 1960s Cardiovascular collapse is the commonest presentation Allergic reactions can be.
The Patient Experience Mr John Hitchman RCoA Lay Representative
The Basics of Intravenous Fluid Administration
Emergency Care Part 3: Surgery in Children with Diabetes
Anaphylaxis: Rapid recognition and treatment
Consultant Clinical Biochemist
Foundations of Interprofessional Collaboration (FIPC): An Introduction to TeamSTEPPS® LEVEL 3 Overview of Clinical Management of Anaphylaxis for Health.
Vasopressor Doses of Epinephrine
Anaphylactic reactions: treatment for adults by first medical responders. *An inhaled β2 agonist such as salbutamol may be used as an adjunctive measure.
Presentation transcript:

Immediate Management Prof Nigel Harper Clinical Lead, NAP6

What we already know Adrenaline is the mainstay of treatment Patients taking beta-blockers may be adrenaline-resistant (glucagon is more effective) Other vasoactive drugs may be effective Metaraminol Noradrenaline Vasopressin Large volumes of IV fluids should be administered ALS protocol should be followed in cardiac arrest Steroids generally accepted to be beneficial Antihistamines may improve urticaria/swelling

What we already know - adrenaline Not the usual first drug for ‘usual’ anaesthesia-induced hypotension Beneficial alpha and beta agonist properties Early administration important Guidelines recommend IV and IM routes AAGBI: 50 mcg repeated as necessary ANZAAG: 100 mcg → 100-200 mcg every 2 mins → infusion after 3rd bolus Reluctance to give adrenaline noted in a Danish study

Recognition and starting specific treatment

Administration of adrenaline Adrenaline not administered in 17.7% of cases Not given when indicated (omitted or late) in 19.4% of cases IV infusion in 31% of cases IM route in 14%, and both in 6% of cases Median dose Grade 3: 200 mcg Grade 4: 500 mcg Grade 5: 4 mg

Other vasoactive drugs Metaraminol given (usually first) in 69% of cases Noradrenaline infusion administered in 19% Phenylephrine administered mainly in obstetric cases Two patients received vasopressin 18% of patients were taking a beta-blocker but only one received glucagon

Steroids and antihistamines Hydrocortisone given in only 83% of cases Dexamethasone given after the event in 16% Dexamethasone given as an antiemetic in 60% of all GAs 7.5mg equivalent to hydrocortisone 200mg Chlorphenamine given in 74% of cases and ranitidine in 5.3% Associated with increased probability of no harm (OR = 2.2) & decreased probability of moderate/severe harm (OR = 0.41) (univariate logistic regression - patient factors and resuscitation drugs) BUT chlorphenamine was strongly associated with good clinical management (P<0.005)

Bronchodilator Drugs Bronchospasm present in almost half Specific bronchodilator used in only ¼ Inhaled salbutamol administered in 10.2% Magnesium sulphate given in 7.4% - may exacerbate hypotension IV salbutamol boluses administered in 4.2% Ketamine and aminophylline used in a few cases

Is sugammadex effective in rocuronium-anaphylaxis? Sugammadex was administered during the first six hours following the event in 19 (7.1%) cases (median dose 300 mg, range 150– 1200 mg). The suspected trigger agent was rocuronium in nine cases, and was the actual culprit in seven When sugammadex was given in rocuronium-anaphylaxis no additional treatment was started in 57%, but further vasopressors or bronchodilators were needed in 43% A similar proportion was seen in non-rocuronium anaphylaxis Compatible with results reported by Platt (2015)

Intravenous Fluids Vital for restoring circulating blood volume and cardiac filling 98% received IV crystalloid in the 1st hour 9% received IV colloid IV Fluid management inappropriate in 19% (usually not enough given) first hour: median 1L subsequent 2 hours: median 1L hours 3 to 5: median 0.5L AAGBI guidelines: ‘Administer saline 0.9% … at a high rate… (large volumes may be required).’ ANZAAG guidelines ‘… repeated fluid boluses of 20mls/kg may be required.’

Outcome of intervention/surgery Procedure unchanged in 35% Procedure not abandoned in 11 cases where it would have been appropriate Patients were more likely to require critical care if surgery had been started In 14% of abandoned cases, it was decided not to re-schedule surgery Median unplanned hospital stay 1 day (range 0 to 150 days) 54% transferred to critical care Level 3: median1 day (1 to 9 days) Level 2: median 1 day (1 to 25 days) estimated cost for the entire cohort £438,102

Recommendations – immediate management Adrenaline is the primary treatment and should be administered immediately anaphylaxis is suspected. In the perioperative setting this will usually be IV A rapid IV crystalloid (not colloid) fluid challenge of 20 ml/kg should be given immediately. This should be repeated several times if necessary Administration of IV vasopressin 2 Units, repeated as necessary, should be considered when hypotension is refractory 
 In patients taking beta- blockers, early administration of IV glucagon 1 mg should be considered, repeated as necessary Perioperative anaphylaxis guidelines and/or a management algorithm should be immediately available Anaesthesia anaphylaxis treatment packs should be immediately available

Thank You